Win the Patent War Before the Drug Goes Generic: How Paragraph IV Challenges and Pay-for-Delay Settlements Decide Who Gets Paid — and Who Gets Blocked
In the high-stakes world of pharmaceuticals, the battle over patent rights isn’t just a legal skirmish—it’s a multi-billion-dollar war that shapes access to life-saving medications, influences healthcare costs, and determines the fate of innovation. Ye…
